logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Kabra Drugs Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524322
    INE323K01017
    10.5817271
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    25.04
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
Date Headline
15-Feb-2025 Kabra Drugs reports standalone net loss of Rs 0.54 crore in the December 2024 quarter
14-Feb-2025 Kabra Drugs Ltd - Financial Results For The Quarter Ended December 31 2024 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015
08-Feb-2025 Kabra Drugs to conduct board meeting
07-Feb-2025 Kabra Drugs Ltd - Board Meeting Intimation for Intimation Of Board Meeting
05-Dec-2024 Kabra Drugs to conduct EGM
04-Dec-2024 Kabra Drugs Ltd - Board Meeting Outcome for In Compliance Of Regulation 30 Of The SEBI (LODR) Regulations 2015 - Outcome Of Board Meeting Held On December 4 2024.
26-Nov-2024 Kabra Drugs schedules board meeting
15-Nov-2024 Kabra Drugs reports standalone net loss of Rs 0.40 crore in the September 2024 quarter
14-Nov-2024 Kabra Drugs Ltd - Financial Results For The Quarter And Half Year Ended September 30 2024 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015
08-Nov-2024 Kabra Drugs to convene board meeting
1 2